甲基-6-氧代-1,6-二氢-4-羧酸结构式
|
常用名 | 甲基-6-氧代-1,6-二氢-4-羧酸 | 英文名 | Methyl 6-oxo-3,6-dihydropyrimidine-4-carboxylate |
|---|---|---|---|---|
| CAS号 | 7399-93-1 | 分子量 | 154.123 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | 263.8±50.0 °C at 760 mmHg | |
| 分子式 | C6H6N2O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 113.3±30.1 °C |
| 中文名 | 6-羟基嘧啶-4-羧酸甲酯 |
|---|---|
| 英文名 | methyl 4-oxo-1H-pyrimidine-6-carboxylate |
| 中文别名 | 6-羟基嘧啶-4-甲酸甲酯 |
| 英文别名 | 更多 |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 沸点 | 263.8±50.0 °C at 760 mmHg |
| 分子式 | C6H6N2O3 |
| 分子量 | 154.123 |
| 闪点 | 113.3±30.1 °C |
| 精确质量 | 154.037842 |
| PSA | 72.05000 |
| LogP | -1.84 |
| 蒸汽压 | 0.0±0.5 mmHg at 25°C |
| 折射率 | 1.580 |
| 储存条件 | 2-8°C |
| 危害码 (欧洲) | Xi |
|---|---|
| 海关编码 | 2933599090 |
|
~69%
甲基-6-氧代-1,6-二氢-4-羧酸 7399-93-1 |
| 文献:AstraZeneca AB Patent: US2009/111821 A1, 2009 ; Location in patent: Page/Page column 23 ; US 20090111821 A1 |
|
~70%
甲基-6-氧代-1,6-二氢-4-羧酸 7399-93-1 |
| 文献:AstraZeneca AB; NPS PHARMACEUTICALS, INC. Patent: US2007/259862 A1, 2007 ; Location in patent: Page/Page column 40 ; US 20070259862 A1 |
| 甲基-6-氧代-1,6-二氢-4-羧酸上游产品 2 | |
|---|---|
| 甲基-6-氧代-1,6-二氢-4-羧酸下游产品 1 | |
| 海关编码 | 2933599090 |
|---|---|
| 中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| 6-Oxo-1,6-dihydro-pyrimidin-4-carbonsaeure-methylester |
| Methyl6-Hydroxypyrimidine-4-carboxylate |
| Methyl 6-oxo-1,6-dihydro-4-pyrimidinecarboxylate |
| methyl 6-oxo-3,6-dihydropyrimidine-4-carboxylate |
| 4-Pyrimidinecarboxylic acid, 3,6-dihydro-6-oxo-, methyl ester |
| 6-oxo-1,6-dihydro-pyrimidine-4-carboxylic acid methyl ester |
| Methyl 6-oxo-1,6-dihydropyrimidine-4-carboxylate |